Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis
Mattía Galli(Maria Cecilia Hospital), Dominick J. Angiolillo(Jacksonville University), Roxana Mehran(Icahn School of Medicine at Mount Sinai), Francesco Franchi(Florida College), Fabiana Rollini(Florida College), Domenico D’Amario(Università Cattolica del Sacro Cuore), Renzo Laborante(Università Cattolica del Sacro Cuore), Davide Capodanno, Luis Ortega‐Paz(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Charles Micheal Gibson(Beth Israel Deaconess Medical Center), Elena Tremoli(University of Milan)
Cited by 62
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k